STCube Inc
KOSDAQ:052020
STCube Inc
Inventory
STCube Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
STCube Inc
KOSDAQ:052020
|
Inventory
₩1.5B
|
CAGR 3-Years
80%
|
CAGR 5-Years
64%
|
CAGR 10-Years
7%
|
|
|
M
|
Makus Inc
KOSDAQ:093520
|
Inventory
₩56B
|
CAGR 3-Years
22%
|
CAGR 5-Years
42%
|
CAGR 10-Years
24%
|
|
|
S
|
SAMT Co Ltd
KOSDAQ:031330
|
Inventory
₩498.2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
40%
|
CAGR 10-Years
22%
|
|
|
D
|
Dmoa Co Ltd
KOSDAQ:016670
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
U
|
Unitron Tech Co Ltd
KOSDAQ:142210
|
Inventory
₩111.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
25%
|
CAGR 10-Years
23%
|
|
|
P
|
PC Direct Inc
KOSDAQ:051380
|
Inventory
₩37.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
STCube Inc
Glance View
STCube, Inc. engages in the development and distribution of information technology (IT) services. The company is headquartered in Seoul, Seoul. The company went IPO on 2001-07-05. Along with subsidiaries, the Company operates its business through two segments. The Information Technology (IT) segment is engaged in the distribution of closed-circuit television (CCTV) lenses and related components. The Biotechnology (BT) segment is engaged in the development and licensing of immunomodulatory anticancer drug therapeutic candidates.
See Also
What is STCube Inc's Inventory?
Inventory
1.5B
KRW
Based on the financial report for Sep 30, 2025, STCube Inc's Inventory amounts to 1.5B KRW.
What is STCube Inc's Inventory growth rate?
Inventory CAGR 10Y
7%
Over the last year, the Inventory growth was 13%. The average annual Inventory growth rates for STCube Inc have been 80% over the past three years , 64% over the past five years , and 7% over the past ten years .
